Gary Meininger

Gary Meininger

Direttore Tecnico/Scientifico/R&S presso SANA BIOTECHNOLOGY, INC.
Health Technology
Consumer Services

Profilo

Gary Meininger currently works at Joslin Diabetes Center, Inc., as Director from 2024 and Sana Biotechnology, Inc., as Chief Medical Officer from 2023.
Dr. Meininger also formerly worked at Johnson & Johnson, as Vice President from 2010 to 2019, Vertex Pharmaceuticals, Inc., as Senior Vice President & Head-Clinical Development from 2020 to 2023, and Merck Research Laboratories Massachusetts LLC, as Principal from 2002 to 2010.
Dr. Meininger received his undergraduate degree from State University of New York at Binghamton and doctorate degree from New York University School of Medicine.

Posizioni attive di Gary Meininger

SocietàPosizioneInizio
SANA BIOTECHNOLOGY, INC. Direttore Tecnico/Scientifico/R&S 10/04/2023
Direttore/Membro del Consiglio 01/10/2024

Precedenti posizioni note di Gary Meininger

SocietàPosizioneFine
VERTEX PHARMACEUTICALS INCORPORATED Direttore Tecnico/Scientifico/R&S 01/03/2023
JOHNSON & JOHNSON Corporate Officer/Principal 01/02/2019
Corporate Officer/Principal 01/07/2010
Vedi nel dettaglio l'esperienza di Gary Meininger

Formazione di Gary Meininger

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

90

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Gary Meininger